,35 The decreased expression of these markers highlights the immunologic impact of dual treatment on CD8+ cytotoxic T-cells in the tumor microenvironment and their potentially enhanced capacity to kill HNSCC tumor cells. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.